Protocol Ledger

NCT04397718 · Phase II · COMPLETED

Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization

Interventional Phase II clinical trial protocol NCT04397718 sponsored by VA Office of Research and Development in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-07-06 Enrollment: 96 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04397718
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)96 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04397718
Protocol FieldVerified Registry Value
NCT IdentifierNCT04397718
Consolidated Lead SponsorVA Office of Research and Development
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment96 participants (ACTUAL)
Registered Start Date2020-07-06
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI